UVA is conducting an FDA-approved clinical trial of prostate artery embolization (PAE), a new interventional therapy that has shown potential for relieving benign prostate hypertrophy symptoms without side effects.
UVA is conducting an FDA-approved clinical trial of prostate artery embolization (PAE), a new interventional therapy that has shown potential for relieving benign prostate hypertrophy symptoms without side effects.